# Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

> **NCT00745199** · PHASE2 · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 62 (actual)

## Conditions studied

- End Stage Renal Disease
- Pruritus

## Interventions

- **DRUG:** cromolyn sodium
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00745199
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-11
- **Final completion:** 2009-06
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2009-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745199, "Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00745199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*